NCT01793818View on ClinicalTrials.gov

Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
AIDS
Interventions
BIOLOGICAL

Tat Oyi

Three injections in the arm

Trial Locations (1)

13385

Centre d'Investigation Clinique - Universitary Hospital Centre Conception, Marseille

Sponsors

Lead Sponsor

BIOSANTECH
All Listed Sponsors
collaborator

Assistance Publique Hopitaux De Marseille

OTHER

lead

BIOSANTECH

INDUSTRY

NCT01793818 - Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein | Biotech Hunter | Biotech Hunter